TIANYIN PHARMACEUTICAL CO., INC.: 10-Q filed 2015-08-20

Name: TIANYIN PHARMACEUTICAL CO., INC.: 10-Q filed 2015-08-20
Creator: TIANYIN PHARMACEUTICAL CO., INC.

What TIANYIN PHARMACEUTICAL CO., INC. reported in its quarterly report filed 2015-08-20 (fiscal Q2 2015): 40 published measures, 109 facts as tagged in accession 0001213900-15-006412.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-08-20
Fiscal period: fiscal Q2 2015
Accession: 0001213900-15-006412 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TIANYIN PHARMACEUTICAL CO., INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-12-31	101,084,392	USD
At 2014-06-30	107,068,729	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-12-31	4,501,222	USD
At 2014-06-30	9,327,903	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-12-31	96,583,170	USD
At 2014-06-30	97,676,805	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-12-31	11,619,292	USD
At 2014-06-30	16,120,041	USD
At 2013-12-31	31,307,119	USD
At 2013-06-30	26,827,008	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	126,184	USD	92
2014-07-01 to 2014-12-31	1,112,009	USD	184
2013-10-01 to 2013-12-31	1,743,608	USD	92
2013-07-01 to 2013-12-31	3,258,731	USD	184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	-1,119,109	USD	184
2013-07-01 to 2013-12-31	1,384,624	USD	184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	6,691,740	USD	92
2014-07-01 to 2014-12-31	16,425,121	USD	184
2013-10-01 to 2013-12-31	13,923,166	USD	92
2013-07-01 to 2013-12-31	28,671,714	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	-1,049,640	USD	184
2013-07-01 to 2013-12-31	3,158,514	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	-2,355,964	USD	184
2013-07-01 to 2013-12-31	-367,234	USD	184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-12-31	51,132,786	USD
At 2014-06-30	50,193,258	USD

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	0	USD/shares	92
2014-07-01 to 2014-12-31	0.04	USD/shares	184
2013-10-01 to 2013-12-31	0.06	USD/shares	92
2013-07-01 to 2013-12-31	0.11	USD/shares	184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	82,336	USD	92
2014-07-01 to 2014-12-31	437,164	USD	184
2013-10-01 to 2013-12-31	727,757	USD	92
2013-07-01 to 2013-12-31	1,361,865	USD	184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-12-31	20,104,121	USD
At 2014-06-30	45,378,356	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	265,337	USD	92
2014-07-01 to 2014-12-31	1,685,708	USD	184
2013-10-01 to 2013-12-31	2,454,213	USD	92
2013-07-01 to 2013-12-31	4,628,404	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-12-31	25,983,904	USD
At 2014-06-30	33,779,520	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	69,819	USD	92
2014-07-01 to 2014-12-31	158,657	USD	184
2013-10-01 to 2013-12-31	119,821	USD	92
2013-07-01 to 2013-12-31	222,722	USD	184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-12-31	4,501,222	USD
At 2014-06-30	9,327,903	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2014-12-31	211,510	USD
At 2014-06-30	211,120	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2014-12-31	2,273,805	USD
At 2014-06-30	9,074,576	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	3,384,920	USD	92
2014-07-01 to 2014-12-31	7,042,467	USD	184
2013-10-01 to 2013-12-31	3,763,084	USD	92
2013-07-01 to 2013-12-31	7,582,408	USD	184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2014-12-31	6,266,299	USD
At 2014-06-30	3,841,712	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	3,650,257	USD	92
2014-07-01 to 2014-12-31	8,728,175	USD	184
2013-10-01 to 2013-12-31	6,217,297	USD	92
2013-07-01 to 2013-12-31	12,210,812	USD	184

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	3,041,483	USD	92
2014-07-01 to 2014-12-31	7,696,946	USD	184
2013-10-01 to 2013-12-31	7,705,869	USD	92
2013-07-01 to 2013-12-31	16,460,902	USD	184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	914,607	USD	92
2014-07-01 to 2014-12-31	2,007,250	USD	184
2013-10-01 to 2013-12-31	252,014	USD	92
2013-07-01 to 2013-12-31	503,328	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-12-31	29,432,791	shares
At 2014-06-30	29,432,791	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-12-31	27,809,515	USD
At 2014-06-30	30,189,802	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2014-12-31	10,598,355	USD
At 2014-06-30	10,423,712	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2014-12-31	96,583,170	USD
At 2014-06-30	97,740,826	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2014-12-31	12,854,610	USD
At 2014-06-30	27,699,733	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	126,184	USD	92
2014-07-01 to 2014-12-31	1,103,706	USD	184
2013-10-01 to 2013-12-31	1,693,059	USD	92
2013-07-01 to 2013-12-31	3,152,551	USD	184

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	300,094	USD	92
2014-07-01 to 2014-12-31	1,286,652	USD	184
2013-10-01 to 2013-12-31	2,178,400	USD	92
2013-07-01 to 2013-12-31	4,305,028	USD	184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	1,253,361	USD	92
2014-07-01 to 2014-12-31	2,189,417	USD	184
2013-10-01 to 2013-12-31	1,082,395	USD	92
2013-07-01 to 2013-12-31	2,111,161	USD	184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	1,285,722	USD	184
2013-07-01 to 2013-12-31	1,297,519	USD	184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2014-10-01 to 2014-12-31	-56,817	USD	92
2014-07-01 to 2014-12-31	-144,838	USD	184
2013-10-01 to 2013-12-31	-33,397	USD	92
2013-07-01 to 2013-12-31	-113,988	USD	184

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	251,571	USD	184
2013-07-01 to 2013-12-31	1,361,865	USD	184

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	135,729	USD	184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	150,808	USD	184
2013-07-01 to 2013-12-31	222,645	USD	184

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	306,992	USD	184
2013-07-01 to 2013-12-31	1,340,918	USD	184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	-6,813,344	USD	184
2013-07-01 to 2013-12-31	563,334	USD	184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2014-07-01 to 2014-12-31	2,416,004	USD	184
2013-07-01 to 2013-12-31	-61,748	USD	184

Inspect the source

Entity: TIANYIN PHARMACEUTICAL CO., INC. / CIK 0001362718
Captured: 2026-09-22 19:45 UTC
SEC response SHA-256: 906628a22ccc64c913be7c41e1b47cf109b535396d641f5e43d99086a9971e90

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001362718.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))